These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6299946)

  • 1. Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.
    Robinson A; Hawkins DC
    Infect Immun; 1983 Feb; 39(2):590-8. PubMed ID: 6299946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.
    Robinson A; Irons LI
    Infect Immun; 1983 May; 40(2):523-8. PubMed ID: 6301999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation and purification of the hemagglutinins from Bordetella pertussis.
    Sato Y; Cowell JL; Sato H; Burstyn DG; Manclark CR
    Infect Immun; 1983 Jul; 41(1):313-20. PubMed ID: 6305841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice.
    Oda M; Cowell JL; Burstyn DG; Manclark CR
    J Infect Dis; 1984 Dec; 150(6):823-33. PubMed ID: 6094673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
    Munoz JJ; Peacock MG
    Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and protective activities of outer membrane proteins from Bordetella.
    González-y-Merchand J; Ruiloba de León S; Estrada-García I; López-Flores C; Ortega-Ortega R; Ruíz-Puente J
    Rev Latinoam Microbiol; 1995; 37(1):33-41. PubMed ID: 7784730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of immunization schedule to standardize antibody response in mice to pertussis vaccines.
    Tiru M; Jäätmaa E; Gillenius P; Askelöf P
    Dev Biol Stand; 1985; 61():469-75. PubMed ID: 2872128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of the lymphocytosis promoting factor-haemagglutinin of Bordetella pertussis by affinity chromatography.
    Irons LI; MacLennan AP
    Biochim Biophys Acta; 1979 Sep; 580(1):175-85. PubMed ID: 232665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase-shift markers in Bordetella: alterations in envelope proteins.
    Ezzell JW; Dobrogosz WJ; Kloos WE; Manclark CR
    J Infect Dis; 1981 Apr; 143(4):562-9. PubMed ID: 6263983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic and protective properties of the 69-kDa outer membrane protein of Bordetella pertussis: a novel formulation for an acellular pertussis vaccine.
    Novotny P; Chubb AP; Cownley K; Charles IG
    J Infect Dis; 1991 Jul; 164(1):114-22. PubMed ID: 2056199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel bivalent acellular pertussis vaccine based on the 69 kDa protein and FHA.
    Novotny P; Chubb AP; Cownley K; Charles IG
    Dev Biol Stand; 1991; 73():243-9. PubMed ID: 1778316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.
    Meade BD; Kind PD; Ewell JB; McGrath PP; Manclark CR
    Infect Immun; 1984 Sep; 45(3):718-25. PubMed ID: 6088394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation.
    Meade BD; Kind PD; Manclark CR
    Infect Immun; 1984 Dec; 46(3):733-9. PubMed ID: 6094357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of an immunoblotting method for identifying the individual proteins in the antigenic complexes of Bordetella pertussis].
    Semina IE; Iankina ZK
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):78-81. PubMed ID: 2568040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human T gamma and non-T gamma cells.
    Kashiwa H; Hyodo S; Kishi T; Karakawa T; Kittaka E; Suzawa T; Sakano T; Usui T
    Clin Exp Immunol; 1984 Nov; 58(2):436-43. PubMed ID: 6094059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular aspects of Bordetella pertussis pathogenesis.
    Locht C
    Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lymphocytosis-promoting factor from Bordetella pertussis on cerebellar cyclic GMP levels.
    Askelöf P; Gillenius P
    Infect Immun; 1982 Jun; 36(3):958-61. PubMed ID: 6284647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis.
    Morse SI; Morse JH
    J Exp Med; 1976 Jun; 143(6):1483-502. PubMed ID: 58054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant.
    Finn TM; Stevens LA
    Mol Microbiol; 1995 May; 16(4):625-34. PubMed ID: 7476158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chick embryo, a model to study the lethal activity of pertussis toxin, infectivity of Bordetella pertussis, and their neutralization by immune sera.
    Calver GA; Burton WW; Gardell CY
    Can J Microbiol; 1993 Aug; 39(8):759-66. PubMed ID: 8106134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.